Replimune Group, Inc. REPL
Set alert
20.14 USD +0.65 +3.34%
As of Nov 3, 1:59 PM ET
19.50 Day range 21.26
1.50 52-week range 21.26
- YTD
- +107.20%
- 1 year
- +116.33%
- Open
- 19.52
- Prev close
- 19.49
- Mkt cap
- 1.91B
- Vol
- 2.92M
- Avg vol
- 2.95M
- EPS
- -2.79
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 19.50
- High
- 21.26
- Forward P/E
- -29.05
- Beta
- 0.93
- Short ratio
- 11.50
- Inst. own
- 105.25%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 2, 2027
- 50-d avg
- 13.58
- 200-d avg
- 9.29
- 1y target
- 23.33
MAX chart
Events in this range
- Nov 6, 2025Earnings: -0.9; estimate -0.87; surprise -3.45%
- Feb 3, 2026Earnings: -0.77; estimate -0.7683; surprise -0.22%
- Jun 29, 2026Earnings: -0.76; estimate -0.73; surprise -4.11%
- Jul 31, 2026Rating: Wedbush · Neutral → Neutral
- Aug 4, 2026Rating: Leerink Partners · Market Perform → Outperform
- Aug 7, 2026Rating: Wedbush · Neutral → Outperform
- Aug 7, 2026Rating: JP Morgan · Overweight → Overweight
- Aug 14, 2026Earnings: -0.72; estimate -0.694; surprise -3.75%
- Aug 26, 2026Rating: JP Morgan · Overweight → Overweight
- Oct 28, 2026Earnings: -0.54; estimate -0.784; surprise 31.12%
- Oct 29, 2026Rating: Leerink Partners · Outperform → Outperform
Signals (147)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Nov 3, 2026 | 3 hours ago |
| SMA: Bullish | Oct 26, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 26, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 5, 2026 | 4 weeks ago |
| SMA: Bearish | Sep 21, 2026 | 1 month ago |
| RSI: Overbought | Aug 24, 2026 | 2 months ago |
| SMA: Bullish | May 25, 2026 | 5 months ago |
| MACD: Buy Signal | May 25, 2026 | 5 months ago |
| SMA: Bullish | May 11, 2026 | 5 months ago |
| SMA: Bearish | Apr 6, 2026 | 7 months ago |
| SMA: Bearish | Apr 6, 2026 | 7 months ago |
| SMA: Bullish | Mar 30, 2026 | 7 months ago |
| SMA: Bullish | Mar 30, 2026 | 7 months ago |
| SMA: Bearish | Mar 9, 2026 | 7 months ago |
| SMA: Bearish | Mar 9, 2026 | 7 months ago |
| SMA: Bullish | Mar 2, 2026 | 8 months ago |
| SMA: Bearish | Feb 23, 2026 | 8 months ago |
| SMA: Bullish | Feb 16, 2026 | 8 months ago |
| SMA: Bullish | Feb 2, 2026 | 9 months ago |
| SMA: Bearish | Jan 26, 2026 | 9 months ago |
Newest 20 of 147.
Analyst view
Consensus: buy
Buy
Price target (mean) 23.33 +15.9% upside
Now 20.14
- Target (low)
- 14.00
- Target (mean)
- 23.33
- Target (high)
- 31.00
Ratings (0m) 8 7 buy · 0 hold · 1 sell
- Strong buy2
- Buy5
- Hold0
- Sell1
- Strong sell0
Recommendation trend
- This month 8
- 1 month ago 8
- 2 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.47035 | -0.4914 – -0.45 | -0.77 | +38.9% | 7.19M | 0.0% | 4 |
| Next quarter | -0.38767 | -0.423 – -0.33 | -0.76 | +49.0% | 16.43M | 0.0% | 3 |
| Current year | -2.01 | -2.01 – -2.01 | -3.38 | +40.5% | 34.83M | 0.0% | 1 |
| Next year | -0.67084 | -1.16 – 0.43 | -2.01 | +66.6% | 195.55M | +461.4% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 29, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Aug 26, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Aug 7, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Aug 7, 2026 | Wedbush | Upgrade | Neutral | Outperform |
| Aug 4, 2026 | Leerink Partners | Upgrade | Market Perform | Outperform |
| Jul 31, 2026 | Wedbush | Maintained | Neutral | Neutral |
| Jul 31, 2026 | Cantor Fitzgerald | Upgrade | Neutral | Overweight |
| Jun 30, 2026 | Wedbush | Maintained | Neutral | Neutral |
| Jun 26, 2026 | JP Morgan | Upgrade | Neutral | Overweight |
| Jun 1, 2026 | Wedbush | Maintained | Neutral | Neutral |
| May 29, 2026 | JP Morgan | Upgrade | Underweight | Neutral |
| Apr 13, 2026 | Cantor Fitzgerald | Downgrade | Overweight | Neutral |
| Apr 13, 2026 | Leerink Partners | Downgrade | Outperform | Market Perform |
| Apr 13, 2026 | JP Morgan | Downgrade | Neutral | Underweight |
| Apr 13, 2026 | Wedbush | Downgrade | Outperform | Neutral |
| Apr 13, 2026 | Jefferies | Downgrade | Buy | Hold |
| Apr 13, 2026 | HC Wainwright & Co. | Downgrade | Buy | Sell |
| Feb 5, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Feb 4, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Nov 3, 2025 | BMO Capital | Upgrade | Underperform | Market Perform |
| Oct 27, 2025 | HC Wainwright & Co. | Upgrade | Neutral | Buy |
| Oct 20, 2025 | JP Morgan | Upgrade | Underweight | Neutral |
| Oct 20, 2025 | Leerink Partners | Upgrade | Market Perform | Outperform |
| Oct 20, 2025 | Wedbush | Upgrade | Neutral | Outperform |
| Sep 19, 2025 | JP Morgan | Downgrade | Neutral | Underweight |
| Sep 8, 2025 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| Jul 30, 2025 | Cantor Fitzgerald | Upgrade | Neutral | Overweight |
| Jul 23, 2025 | BMO Capital | Downgrade | Outperform | Underperform |
| Jul 23, 2025 | Barclays | Downgrade | Overweight | Equal-Weight |
| Jul 23, 2025 | HC Wainwright & Co. | Downgrade | Buy | Neutral |